A Phase II Multicenter, Double-blind, Randomized, Placebo-Controlled Study of Three Dosages of an Immunomodulator (PGG-Glucan) in High-Risk Surgical Patients
- 1 November 1994
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 129 (11) , 1204-1210
- https://doi.org/10.1001/archsurg.1994.01420350102014
Abstract
Research from JAMA Surgery — A Phase II Multicenter, Double-blind, Randomized, Placebo-Controlled Study of Three Dosages of an Immunomodulator (PGG-Glucan) in High-Risk Surgical PatientsKeywords
This publication has 3 references indexed in Scilit:
- Spectral analysis of glucan produced by wild-type and mutant saccharomyces cerevisiaeCarbohydrate Polymers, 1990
- The Distinction Between Cost and ChargesAnnals of Internal Medicine, 1982
- Glucan-induced modification of the increased susceptibility of cyclophosphamide-treated mice to Staphylococcus aureus infectionCancer Immunology, Immunotherapy, 1979